Related Experiment Video
Updated: Nov 22, 2025
11:49
Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model
Published on: September 9, 2011
20.8K
Tunable Polymer Embolic Implant for Vascular Occlusion
ACS Biomaterials Science & Engineering
|January 6, 2021
Summary
Researchers created a tunable polymer vascular embolic implant (TPVEI) with adjustable precipitation for controlled vascular occlusion. Modifying solvent miscibility precisely controls embolization depth in endovascular therapies.
Area of Science:
- Biomaterials Science
- Vascular Surgery
- Medical Imaging
Background:
- Vascular occlusion is crucial for endovascular therapies.
- Current embolic agents lack precise control over occlusion depth.
- Developing tunable embolic materials is essential for improved treatment outcomes.
Purpose of the Study:
- To develop a tunable polymer vascular embolic implant (TPVEI) with adjustable precipitation rates.
- To investigate the effect of solvent miscibility on TPVEI precipitation and vascular occlusion depth.
- To evaluate the homogeneous vascular distribution and occlusion control of TPVEI in vivo.
Main Methods:
- TPVEI synthesized with varying NMP/BB solvent ratios.
- Direct injection of TPVEI into the rat portal vein.
- MicroCT and Broadband Doppler ultrasound for imaging and validation.
Main Results:
- Adjusting NMP/BB ratio significantly altered occluded vessel size (p < 0.05).
- 60/40 NMP/BB formulation achieved homogeneous distribution across liver vasculature.
- Complete portal vein occlusion confirmed by ultrasound post-embolization.
Conclusions:
- Solvent polarity adjustment offers precise control over embolization depth.
- Phase-inverting embolics can be optimized for enhanced endovascular therapy.
- TPVEI demonstrates potential for personalized, controlled vascular occlusion.
